FundedIQ
Biotechnology

Armata Pharmaceuticals: Funding, Investors & Team (Oct 2026)

Armata Pharmaceuticals is a biotechnology company that is in the process of developing bacteriophage therapeutics that are targeted specifically for drug-resistant bacterial infections. Due to the excessive use of antibiotics, there has been a significant increase in multidrug-resistant bacteria, which has brought us closer to a time where common infections can be severe or even life-threatening. Furthermore, the use of broad-spectrum antibiotics has been known to disrupt the balance of the human microbiome, leading to disease. Established in 2005, the company is located in Marina del Rey, CA, USA.

www.armatapharma.com LinkedIn Marina Del Rey, United States 51-100 employees
Biotechnology Health Care Health Diagnostics Therapeutics
Total raised
$105M
Rounds
8
Latest
Undisclosed round
Jun 2026

Armata Pharmaceuticals has raised $105M across 8 funding rounds on record, the most recent an undisclosed round of $2.5M announced in Jun 2026.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Armata Pharmaceuticals Company Profile and Key Stats

Total funding raised
$105M
across 8 rounds on record
Funding rounds on record
8
Latest funding round
Undisclosed round
$2.5M in Jun 2026
Employees
51-100
reported band
Headquarters
Marina Del Rey, United States

Latest funding round on record: Jun 2026.

Armata Pharmaceuticals Funding Rounds

Date
Round
Amount
Undisclosed round
$2.5M
Undisclosed round
$15.0M
Undisclosed round
$4.7M
Undisclosed round
$10.0M
Undisclosed round
$5.3M
Undisclosed round
$35.0M
Undisclosed round
$25.0M
Post-IPO Equity
$7.0M

Armata Pharmaceuticals raised $7.0M in a Post-IPO Equity announced in Oct 2021.

1.8 years later, an undisclosed round of $25.0M was announced in Jul 2023.

8 months later, an undisclosed round of $35.0M was announced in Mar 2024.

4 months later, an undisclosed round of $5.3M was announced in Jul 2024.

8 months later, an undisclosed round of $10.0M was announced in Mar 2025.

2 months later, an undisclosed round of $4.7M was announced in May 2025.

3 months later, an undisclosed round of $15.0M was announced in Aug 2025.

10 months later, an undisclosed round of $2.5M was announced in Jun 2026.

Armata Pharmaceuticals Founders and Leadership Team

Name
Role
Contact
Todd Patrick
Founder
—
Wenyuan Shi
Founder
Locked
Brian Varnum
CEO
—

Contact details for the Armata Pharmaceuticals team: 1 of 3 have an email address on file.

Start 14-day free trial →

Armata Pharmaceuticals Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Armata Pharmaceuticals' latest round of $2.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Armata Pharmaceuticals in Biotechnology and Marina Del Rey

Companies Similar to Armata Pharmaceuticals

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Armata Pharmaceuticals Funding FAQs

What does Armata Pharmaceuticals do?

Armata Pharmaceuticals is a biotechnology company that is in the process of developing bacteriophage therapeutics that are targeted specifically for drug-resistant bacterial infections. Due to the excessive use of antibiotics, there has been a significant increase in multidrug-resistant bacteria, which has brought us closer to a time where common infections can be severe or even life-threatening. Furthermore, the use of broad-spectrum antibiotics has been known to disrupt the balance of the human microbiome, leading to disease. Established in 2005, the company is located in Marina del Rey, CA, USA.

How much funding has Armata Pharmaceuticals raised?

Armata Pharmaceuticals has raised $105M across 8 rounds on record. The most recent is an undisclosed round of $2.5M announced in Jun 2026.

When did Armata Pharmaceuticals last raise funding?

Armata Pharmaceuticals' most recent funding round on record is an undisclosed round of $2.5M, announced in Jun 2026.

Who founded Armata Pharmaceuticals?

FundedIQ lists Todd Patrick (Founder), Wenyuan Shi (Founder) at Armata Pharmaceuticals.

Who is the CEO of Armata Pharmaceuticals?

Brian Varnum is listed as CEO at Armata Pharmaceuticals.

Where is Armata Pharmaceuticals headquartered?

Armata Pharmaceuticals is based in Marina Del Rey, California, United States.

How many employees does Armata Pharmaceuticals have?

Armata Pharmaceuticals is in the 51-100 employee band.

How does Armata Pharmaceuticals' funding compare to other Biotechnology startups?

Armata Pharmaceuticals' latest round of $2.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Armata Pharmaceuticals Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Armata Pharmaceuticals is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.